Post Content
Stacie Calad-Thomson, North America business development lead for healthcare and life sciences at NVIDIA, discusses how generative, agentic, and physical AI advancements driven by the NVIDIA BioNeMo platform are reshaping the field of drug discovery.
Learn more: https://www.nvidia.com/en-us/clara/biopharma/ Read More NVIDIA
#Techno #nvidia
